Senior Director, Drug Safety and Pharmacovigilance
Location: Waltham
Posted on: June 23, 2025
|
|
Job Description:
Company Overview: Dyne Therapeutics is discovering and advancing
innovative life-transforming therapeutics for people living with
genetically driven neuromuscular diseases. Leveraging the
modularity of its FORCE™ platform, Dyne is developing targeted
therapeutics that deliver to muscle and the central nervous system
(CNS). Dyne has a broad pipeline for neuromuscular diseases,
including clinical programs for myotonic dystrophy type 1 (DM1) and
Duchenne muscular dystrophy (DMD) and preclinical programs for
facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.
Role Summary: The Senior Director, Drug Safety and
Pharmacovigilance will play a key leadership role in characterizing
the safety profiles of Dyne products and mitigating and
communicating their risks throughout the product lifecycle (from
First-In-Human to post-marketing). This role will provide short-
and long-term strategic leadership of safety surveillance for
Dyne’s clinical development programs, including resource planning
and long-range capability development to ensure high quality
characterization of the safety profiles of Dyne molecules and
compliance with all applicable US and foreign legal and regulatory
requirements for pharmacovigilance, signal management and risk
management. This role will oversee cross-functional Signal
Detection and Safety Surveillance Teams, guiding the analysis,
interpretation and presentation of safety data to stakeholders as
needed. This role also contributes to the safety content of
regulatory and study documents and collaborates actively with
colleagues in numerous cross-functional departments. This role is
based in Waltham, MA without the possibility of being fully remote.
Primary Responsibilities Include: Conduct and/or oversee activities
related to signal detection and evaluation, risk classification,
management and communication, including leadership of Signal
Detection and Safety Surveillance Teams, as part of continuous
benefit-risk evaluation throughout the lifecycle of Dyne products
from First-in-Human (FIH) to post-marketing Review safety data of
non-clinical studies and from other sources to inform clinical
development safety monitoring strategies and plans, including
identification of safety-related biomarkers Contribute to the
Safety Governance process through the preparation and presentation
of safety data and provision of recommendations for review and
approval by the Safety Management Committee Perform medical review
of ICSRs in Dyne’s Global Safety Database including but not limited
to case narrative, MedDRA coding, causality, company comment and
queries Develop Aggregate Safety Reports (ASR) such as Development
Safety Update Report (DSUR), and responses to health authorities’
requests for safety information Contribute to safety sections of
clinical study documents including Study Protocols, Informed
Consent Forms (ICF), Statistical Analysis Plans (SAP), IB Reference
Safety Information (RSI), Clinical Study Reports (CSR), Summary of
Clinical Safety (SCS), Integrated Clinical Safety (ICS),
Publications, and other relevant documents Provide strategic
guidance and draft responses to safety-related requests and
questions from Health Authorities Assist in planning the
Pharmacovigilance Department budget, develop short-term and
long-term goals for the department in accordance with overall
Company and Development strategies Review safety content of
scientific publications such as posters, abstracts, and
manuscripts. Participate in cross-functional projects and teams
Engage with external consultants and advisors as needed to inform
interpretation of emerging safety signals. Serve as an exemplary
leader, mentor, and trainer Education and Skills Requirements: MD
is required Minimum 12 years’ experience as a safety physician with
the biotechnology / pharmaceutical industry, leading drug safety &
pharmacovigilance, including cross-functional team leadership for
signal detection, evaluation, risk classification and management,
and communication, for products across multiple stages of
development Experience with safety data visualization tools and
other technologies supporting safety surveillance Excellent verbal
communication and presentation skills with ability to write clearly
and concisely, and to formulate science-based arguments in
addressing questions regarding safety from Health Authorities and
other parties, and in characterization of the safety profiles of
Dyne molecules in development Experience in authoring DSUR and
other aggregate safety reports Broad knowledge of FDA and EMA
regulations, GCP/GVP/ICH guidelines, and other local/global safety
regulations, and ability to integrate relevant aspects of these
documents into safety surveillance and reporting Line management /
direct reports experience is strongly preferred In-depth
understanding of observational studies used in pharmacoepidemiology
and ability to provide sound critique of such studies Strong
knowledge of statistical methods used in PV Proven abilities to
lead significant process improvements in PS Exceptional
interpersonal skills and understanding of team dynamics.
Understanding and application of pharmacology, chemistry and
non-clinical toxicology to effectively inform the conduct of safety
surveillance Ability to thrive in a fast-paced environment while
providing appropriate attention to detail. Ability to effectively
present recommendations / opinions in group environment both
internally and externally LI-Onsite The statements contained herein
reflect general details as necessary to describe the principles
functions for this job, the level of knowledge and skill typically
required, and the scope of responsibility, but should not be
considered an all-inclusive listing of work requirements.
Individuals may perform other duties as assigned, including work in
other functional areas to cover absences or relief, to equalize
peak work periods or otherwise balance workload. This description
is not intended to be constructed as an exhaustive list of duties,
responsibilities, or requirements for the position. This position
may change or assume additional duties at any time. The employee
may be requested to perform different or additional duties as
assigned. All Employees are expected to adhere to all company
policies and act as a role model for company values. Dyne
Therapeutics is an equal opportunity employer and will not
discriminate against any employee or applicant on the basis of age,
color, disability, gender, national origin, race, religion, sexual
orientation, veteran status, or any classification protected by
federal, state, or local law.
Keywords: , Chicopee , Senior Director, Drug Safety and Pharmacovigilance, Science, Research & Development , Waltham, Massachusetts